A detailed history of Advisor Group Holdings, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 84,804 shares of CRSP stock, worth $3.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
84,804
Previous 88,401 4.07%
Holding current value
$3.39 Million
Previous $4.77 Million 16.55%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$44.62 - $62.75 $160,498 - $225,711
-3,597 Reduced 4.07%
84,804 $3.98 Million
Q2 2024

Aug 13, 2024

SELL
$51.17 - $68.18 $135,600 - $180,677
-2,650 Reduced 2.91%
88,401 $4.77 Million
Q1 2024

May 10, 2024

BUY
$60.67 - $89.12 $35,309 - $51,867
582 Added 0.64%
91,051 $6.21 Million
Q4 2023

Feb 12, 2024

SELL
$38.62 - $72.18 $504,068 - $942,093
-13,052 Reduced 12.61%
90,469 $5.66 Million
Q3 2023

Nov 13, 2023

BUY
$45.39 - $59.0 $830,637 - $1.08 Million
18,300 Added 21.47%
103,521 $4.7 Million
Q2 2023

Aug 21, 2023

SELL
$43.47 - $67.77 $479,387 - $747,367
-11,028 Reduced 11.46%
85,221 $4.78 Million
Q2 2023

Aug 10, 2023

BUY
$43.47 - $67.77 $487,689 - $760,311
11,219 Added 13.19%
96,249 $5.4 Million
Q1 2023

May 12, 2023

BUY
$41.0 - $56.12 $660,715 - $904,373
16,115 Added 23.38%
85,030 $3.85 Million
Q4 2022

Feb 10, 2023

BUY
$39.19 - $65.67 $700,168 - $1.17 Million
17,866 Added 35.0%
68,915 $2.8 Million
Q3 2022

Nov 14, 2022

BUY
$61.1 - $83.78 $7,270 - $9,969
119 Added 0.23%
51,049 $3.34 Million
Q2 2022

Aug 10, 2022

SELL
$43.23 - $73.83 $27,234 - $46,512
-630 Reduced 1.22%
50,930 $3.12 Million
Q1 2022

May 04, 2022

BUY
$53.19 - $79.24 $509,400 - $758,881
9,577 Added 22.81%
51,560 $3.07 Million
Q3 2021

Nov 05, 2021

BUY
$110.2 - $156.64 $773,604 - $1.1 Million
7,020 Added 20.08%
41,983 $4.7 Million
Q2 2021

Aug 02, 2021

BUY
$100.84 - $161.89 $496,132 - $796,498
4,920 Added 16.38%
34,963 $5.65 Million
Q1 2021

May 13, 2021

BUY
$110.72 - $210.04 $1.38 Million - $2.62 Million
12,476 Added 71.02%
30,043 $3.65 Million
Q4 2020

Feb 10, 2021

SELL
$79.67 - $173.23 $326,886 - $710,762
-4,103 Reduced 18.93%
17,567 $2.69 Million
Q3 2020

Nov 12, 2020

BUY
$78.5 - $100.64 $178,273 - $228,553
2,271 Added 11.71%
21,670 $1.81 Million
Q2 2020

Aug 14, 2020

BUY
$38.5 - $76.05 $8,547 - $16,883
222 Added 1.16%
19,399 $1.43 Million
Q1 2020

May 18, 2020

BUY
$33.68 - $62.53 $645,881 - $1.2 Million
19,177 New
19,177 $821,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.12B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.